Incidence of Unanticipated Uterine Pathology at the Time ofMinimally Invasive Abdominal Sacrocolpopexy

Study Objective: To determine the incidence of unanticipated uterine pathologic findings in women undergoing hysterectomy concomitant with minimally invasive sacrocolpopexy. Design: Retrospective case series (Canadian Task Force classification III). Setting: Four institutions in the United States. Patients: Women undergoing laparoscopic or robotically assisted sacrocolpopexy with hysterectomy. Interventions: Concurrent hysterectomy and minimally invasive sacrocolpopexy. Measurements and Main Results: We measured the incidence of clinically important uterine disease at minimally invasive sacrocolpopexy. A total of 324 women underwent concurrent hysterectomy and minimally invasive sacrocolpopexy. Their mean age was 56.1years, and body mass index was 26.9kg/m². Sixty-four percent were postmenopausal. Only 3 patients (0.92%) had abnormal uterine pathologic findings. No significant differences were noted in age, body mass index, or parity between the women with normal and abnormal uterine pathologic findings. None of the 3 women reported abnormal uterine bleeding before surgery. All lesions were premalignant and focal. No invasive carcinomas were identified. No patients required further follow-up or treatment of abnormal pathologic findings. Conclusion: The risk of unanticipated uterine pathologic findings during minimally invasive sacrocolpopexy to treat pelvic organ prolapse is low.